Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Bain Capital Life Sciences Investors LLC | 10% Owner | 2025-01-08 | 300,000 | $5.76 | $1.73MBuy |
G. Walmsley Graham | Director | 2024-12-17 | 700,761 | $6.75 | $4.73MSell |
G. Walmsley Graham | Director | 2024-12-17 | 700,761 | $6.75 | $4.73MBuy |
Naseem Zojwalla | CHIEF MEDICAL OFFICER | 2024-12-16 | 14,000 | $4.87 | $68.18kBuy |
G. Walmsley Graham | Director | 2024-12-13 | 700,761 | $6.75 | $4.73MSell |
G. Walmsley Graham | Director | 2024-12-13 | 700,761 | $6.75 | $4.73MBuy |
David C. Myles | CH. DISCOV. NON-CLIN DEV OFF | 2024-12-11 | 300 | $9.39 | $2.82kSell |
David C. Myles | CH. DISCOV. NON-CLIN DEV OFF | 2024-12-11 | 13,314 | $8.66 | $115.30kSell |
Shane William Charles Kovacs | CH. OPERATING FINANCIAL OFF. | 2024-12-11 | 406 | $9.39 | $3.81kSell |
Cyrus Harmon | Director | 2024-12-11 | 179 | $9.39 | $1.68kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Bain Capital Life Sciences Investors LLC | 13.09% | 7,500,000 | $37.28M | Insider |
Bain Capital Life Sciences Investors LLC | 13.04% | 7,470,214 | $37.13M | Institution |
Paradigm Biocapital Advisors LP | 12.75% | 7,304,970 | $36.31M | Institution |
Paradigm Biocapital Advisors LP | 9.61% | 5,503,600 | $27.35M | Insider |
Blackrock Inc | 6.61% | 3,789,832 | $18.84M | Institution |
Deep Track Capital LP | 6.01% | 3,442,833 | $17.11M | Institution |
Cormorant Asset Management LP | 5.71% | 3,270,544 | $16.25M | Insider |
Logos Global Management LP | 5.60% | 3,208,875 | $15.95M | Institution |
Vanguard Group Inc | 4.69% | 2,685,009 | $13.34M | Institution |
Pictet Asset Management Holding Sa | 3.29% | 1,883,354 | $9.36M | Institution |